FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3191821 · Received June 26, 2013

Report

Report Number
1030489-2013-02560
Event Type
Injury
Date Received
June 26, 2013
Report Date
December 12, 2016
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). (B)(6). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT AN ANTERIOR LUMBAR INTERBODY FUSION, AS WELL AS A POSTERIOR SPINAL FUSION USING RHBMP-2/ACS. SUBSEQUENTLY, THE PATIENT WAS DIAGNOSED WITH INJURIES, INCLUDING BUT NOT LIMITED TO, ECTOPIC BONE GROWTH, AN INFLAMMATORY REACTION TO RHBMP-2/ACS, CHRONIC PAIN, AND ADDITIONAL SURGERIES. THE PATIENT HAS REQUIRED EXTENSIVE MEDICAL TREATMENT. REPORTEDLY, THE PATIENT HAS NEVER RECOVERED FROM HIS SURGERY INVOLVING RHBMP-2/ACS, AND HE CONTINUES TO HAVE DAILY SEVERE DISABLING PAIN THAT PREVENTS HIM FROM PERFORMING MANY BASIC ACTIVITIES OF DAILY LIVING.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON: (B)(6) 2006: PATIENT PRESENTED WITH FOLLOWING PRE-OP DIAGNOSES: DEGENERATIVE DISK DISEASE L5-S1. FOR WHICH, PATIENT UNDERWENT FOLLOWING PROCEDURES: ANTERIOR LUMBAR INTERBODY FUSION WITH INSERTION OF BIOMECHANICAL DEVICE AND INSTRUMENTATION. POSTERIOR SPINAL FUSION L5-S1. PER OP NOTES, ONCE THE L5-S1 INTERSPACE WAS EXPOSED, AN APPROPRIATE SIZED INTERBODY SPACER WAS IMPACTED INTO PROPER POSITION. A SMALL SPONGE OF BMP WAS APPLIED IN THE FEMORAL RING. THE FACETS AT L5-S1 WERE ALSO DENUDED AND DESTROYED AND THIS BONE GRAFT WAS PLACED OUT POSTEROLATERALLY. PATIENT TOLERATED THE PROCEDURE WELL WITHOUT ANY INTRAOPERATIVE COMPLICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
291006 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 35 YR Required Intervention